5th EACTS Mechanical Circulatory Support Summit

The 5th EACTS Mechanical Circulatory Support Summit will run from 19-21 November 2020 in Bad Oeynhausen, Germany. THURSDAY 19 NOVEMBER (08:00-18:15) 08:00 Welcome 08:15 Session 1: Current status of heart failure therapy Epidemiology and global projections Heart failure therapy: Drugs Heart failure therapy: Interventions Heart failure therapy: MCS Panel discussion 10:00 Break 10:30 EACTS MCS … Continue reading "5th EACTS Mechanical Circulatory Support Summit"

The 5th EACTS Mechanical Circulatory Support Summit will run from 19-21 November 2020 in Bad Oeynhausen, Germany.

THURSDAY 19 NOVEMBER (08:00-18:15)
08:00 Welcome
08:15 Session 1: Current status of heart failure therapy
Epidemiology and global projections
Heart failure therapy: Drugs
Heart failure therapy: Interventions
Heart failure therapy: MCS
Panel discussion
10:00 Break
10:30 EACTS MCS Lifetime Recognition Award
10:45 Session 2: Registries
MCS database: United Kingdom
MCS database: Australia
EUROMACS report
MEDAMACS report
IMACS / INTERMACS report
Panel discussion
Featured lecture: Lessons from space
12:15 Lunch
13:15 Session 3: Pediatric MCS
PediMACS
Acute MCS in children
Durable MCS in children
Bridge to transplant (BTT) in pediatric patients – viable option?
MCS in the grown up congenital heart (GUCH) population
Panel discussion
14:45 Session 4: The perioperative setting
Preimplant optimization
Individualised anticoagulation in VAD therapy
Challenges on the ICU: Key strategies for fast recovery
Preparing for discharge – the ambulatory patient
Panel discussion
16:15 Break
16:45 Session 5: Rehabilitation after MCS
Physical exercise in space: Lessons to learn for the critically ill ICU patient
Nutritional and physical status in VAD candidates: Impact on long-term outcomes
Physical rehabilitation after VAD implantation
Psychological/social rehabilitation after VAD implantation
Panel discussion
18:15 Close
Welcome reception (18:15-19:30)
FRIDAY 20 NOVEMBER (08:00-18:00)
08:00 Session 6: Novelties in MCS engineering
The ideal VAD – what do we need?
The ideal VAD – what can we expect?
Partial support
Biocompatibility
Panel discussion
09:30 Session 7: Adverse events (Case oriented)
Driveline / device infections
Thromboembolic events
Bleeding
Right ventricular heart failure
Arrhythmias
Panel discussion
10:40 Break
11:00 Session 8: My biggest challenges in VAD surgery: Lessons from the most experienced surgeons
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Panel discussion
12:30 Lunch
13:30 5th Rising Stars Quiz
14:30 Session 9: Bridge to transplantation (BTT)
New categories in LVAD-therapy: Have bridge to transplant (BTT) and destination therapy (DT) become obsolete?
Ex vivo organ perfusion
Heart transplantation in LVAD patients: A high risk procedure?
Enlargement of the donor pool: DCD donation for heart transplantation
Panel discussion
15:35 Session 10: Long-term support
Cardiac comorbidity in LVAD patients and their influence on long-term outcomes
Key to success in ultra long-term LVAD support: Patient characteristics
Management and prevention of aortic valve regurgitation in destination therapy (DT) patients
Will VAD therapy replace heart transplantation?
Panel discussion
16:30 Break
16:50 Session 11: Short-term MCS and cardiogenic shock
Cardiogenic shock revisited
Impella as percutaneous VAD in cardiogenic shock
Transition from termporary to durable MCS
Transplant following ECLS
Panel discussion
18:00 Close
SATURDAY 21 NOVEMBER (08:00-14:00)
08:00 Session 12: Right ventricular heart failure
Pathophysiolgy of right ventricular failure in LVAD therapy and patients selection for biventricular support
Less invasive implantation = less right ventricular failure?
Extracorporeal RVAD in acute right ventricular failure
Percutaneous right heart support in LVAD patients
Panel discussion
09:00 Session 13: EACTS Heart failure session
10:00 Break
10:30 Session 14: Challenges in ongoing VAD therapy
Pump thrombosis: VAD exchange or lysis?
Optimized heart failure therapy in VAD patients
Surgical options for VAD infections
Bacteriophages in VAD related infections
Chronic right heart failure: Myth or reality
Panel discussion
11:30 Session 15: Future of VAD patient management
The fully implantable device
Indications and interactions with other medical devices
Hemodynamic guidance with CardioMEMS in VAD therapy
The intelligent VAD: Future perspectives
My LVAD.com
12:30 Session 16: Update of current and upcoming devices
13:45 Closing Remarks

 

Programme subject to change

Summit INFORMATION

Date/Duration
19-21 November 2020 (3 day course)

Location
Bad Oeynhausen, Germany

Chairmen
J Gummert, Bad Oeynhausen; V Falk, Berlin and I Netuka, Prague

Registration Fee
To be announced

Summit Format
Interactive lectures, live-in-a-box cases and keynote presentations

Target Audience
Cardiologists, heart failure cardiologists, emergency and ICU specialists (ECLS), cardiac surgeons, perfusionists, heart failure nurses and ventricular assist device (VAD) coordinators, medical industry (cardiac devices including ECMO development and production). Paediatric cardiologists and congenital heart disease surgeon.

Please click here for the EACTS Academy terms and conditions.